Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.75
Delayed Data
As of May 27
 -0.34 / -0.79%
Today’s Change
36.71
Today|||52-Week Range
44.85
+7.46%
Year-to-Date
3 Value Stocks Near 52-Week Lows Worth Buying
May 27 / MotleyFool.com - Paid Partner Content
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
May 25 / Zacks.com - Paid Partner Content
Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans
May 27 / Zacks.com - Paid Partner Content
4 Safe Stocks With Dividend Yields Above 5%
May 25 / MotleyFool.com - Paid Partner Content
Why Alnylam Pharmaceuticals, Inc. Competed Higher Today
May 26 / MotleyFool.com - Paid Partner Content
PhaseRX: The Latest Pick From a Legendary VC Firm
May 24 / GuruFocus News - Paid Partner Content
Why Ionis Pharmaceuticals Plummeted Today
May 26 / MotleyFool.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
May 24 / Zacks.com - Paid Partner Content
Alnylam Rises After Ionis Partner Decides Not To Start Phase 3 Study
May 26 / TheStreet.com - Paid Partner Content
3 Stocks With a Bigger Dividend Than Coca-Cola
May 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close43.09
Today’s open42.72
Day’s range42.68 - 42.95
Volume2,043,863
Average volume (3 months)3,583,038
Market cap$105.0B
Dividend yield5.46%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+13.86%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-3.66%
P/E ratio170.1
Price/Sales2.70
Price/Book13.83

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.15+0.36%
NVONovo Nordisk-0.61-1.09%
ABBVAbbVie+0.81+1.31%
BMYBristol-Myers Squibb+0.58+0.82%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs